KKR & CO INC (KKR)

US48251W1045 - Common Stock

147.58  +4.05 (+2.82%)

After market: 147.58 0 (0%)

Fundamental Rating

4

Overall KKR gets a fundamental rating of 4 out of 10. We evaluated KKR against 220 industry peers in the Capital Markets industry. Both the profitability and financial health of KKR have multiple concerns. KKR is valued quite expensive, but it does show an excellent growth.



2

1. Profitability

1.1 Basic Checks

KKR had positive earnings in the past year.
KKR had a positive operating cash flow in the past year.
Of the past 5 years KKR 4 years were profitable.
KKR had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

KKR's Return On Assets of 0.83% is on the low side compared to the rest of the industry. KKR is outperformed by 70.97% of its industry peers.
KKR's Return On Equity of 12.42% is fine compared to the rest of the industry. KKR outperforms 68.20% of its industry peers.
KKR has a worse Return On Invested Capital (0.26%) than 80.18% of its industry peers.
Industry RankSector Rank
ROA 0.83%
ROE 12.42%
ROIC 0.26%
ROA(3y)0.85%
ROA(5y)1.65%
ROE(3y)12.4%
ROE(5y)13.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 12.41%, KKR is in line with its industry, outperforming 42.40% of the companies in the same industry.
In the last couple of years the Profit Margin of KKR has declined.
Looking at the Operating Margin, with a value of 4.08%, KKR is doing worse than 79.26% of the companies in the same industry.
In the last couple of years the Operating Margin of KKR has grown nicely.
KKR's Gross Margin of 33.28% is on the low side compared to the rest of the industry. KKR is outperformed by 71.43% of its industry peers.
KKR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.08%
PM (TTM) 12.41%
GM 33.28%
OM growth 3Y-20.76%
OM growth 5Y4.13%
PM growth 3Y-17.4%
PM growth 5Y-10.34%
GM growth 3Y-19.32%
GM growth 5Y-11.66%

1

2. Health

2.1 Basic Checks

KKR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, KKR has more shares outstanding
Compared to 1 year ago, KKR has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.21, we must say that KKR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.21, KKR is doing worse than 75.12% of the companies in the same industry.
The Debt to FCF ratio of KKR is 6.42, which is on the high side as it means it would take KKR, 6.42 years of fcf income to pay off all of its debts.
KKR has a Debt to FCF ratio (6.42) which is comparable to the rest of the industry.
KKR has a Debt/Equity ratio of 2.06. This is a high value indicating a heavy dependency on external financing.
KKR has a Debt to Equity ratio of 2.06. This is in the lower half of the industry: KKR underperforms 77.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF 6.42
Altman-Z 0.21
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.28 indicates that KKR may have some problems paying its short term obligations.
KKR has a worse Current ratio (0.28) than 80.18% of its industry peers.
KKR has a Quick Ratio of 0.28. This is a bad value and indicates that KKR is not financially healthy enough and could expect problems in meeting its short term obligations.
KKR has a Quick ratio of 0.28. This is amonst the worse of the industry: KKR underperforms 80.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.28

9

3. Growth

3.1 Past

KKR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.93%, which is quite impressive.
KKR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.67% yearly.
KKR shows a strong growth in Revenue. In the last year, the Revenue has grown by 78.71%.
Measured over the past years, KKR shows a very strong growth in Revenue. The Revenue has been growing by 42.06% on average per year.
EPS 1Y (TTM)32.93%
EPS 3Y24.32%
EPS 5Y10.67%
EPS Q2Q%56.82%
Revenue 1Y (TTM)78.71%
Revenue growth 3Y49.72%
Revenue growth 5Y42.06%
Sales Q2Q%36.28%

3.2 Future

The Earnings Per Share is expected to grow by 23.48% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 26.56% on average over the next years. This is a very strong growth
EPS Next Y40.03%
EPS Next 2Y33.91%
EPS Next 3Y30.02%
EPS Next 5Y23.48%
Revenue Next Year22.27%
Revenue Next 2Y30.7%
Revenue Next 3Y26.56%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

3

4. Valuation

4.1 Price/Earnings Ratio

KKR is valuated quite expensively with a Price/Earnings ratio of 33.24.
Based on the Price/Earnings ratio, KKR is valued a bit more expensive than the industry average as 73.73% of the companies are valued more cheaply.
KKR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.73.
Based on the Price/Forward Earnings ratio of 24.07, the valuation of KKR can be described as rather expensive.
Based on the Price/Forward Earnings ratio, KKR is valued a bit more expensive than 64.98% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of KKR to the average of the S&P500 Index (22.83), we can say KKR is valued inline with the index average.
Industry RankSector Rank
PE 33.24
Fwd PE 24.07

4.2 Price Multiples

KKR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 16.91
EV/EBITDA N/A

4.3 Compensation for Growth

KKR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as KKR's earnings are expected to grow with 30.02% in the coming years.
PEG (NY)0.83
PEG (5Y)3.12
EPS Next 2Y33.91%
EPS Next 3Y30.02%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.49%, KKR is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 9.45, KKR is paying slightly less dividend.
With a Dividend Yield of 0.49, KKR pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.49%

5.2 History

The dividend of KKR has a limited annual growth rate of 0.22%.
KKR has been paying a dividend for at least 10 years, so it has a reliable track record.
KKR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)0.22%
Div Incr Years5
Div Non Decr Years5

5.3 Sustainability

20.15% of the earnings are spent on dividend by KKR. This is a low number and sustainable payout ratio.
KKR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP20.15%
EPS Next 2Y33.91%
EPS Next 3Y30.02%

KKR & CO INC

NYSE:KKR (12/20/2024, 8:21:17 PM)

After market: 147.58 0 (0%)

147.58

+4.05 (+2.82%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)10-24 2024-10-24/bmo
Earnings (Next)02-04 2025-02-04/amc
Inst Owners61.58%
Inst Owner Change-1.3%
Ins Owners23.96%
Ins Owner Change0.01%
Market Cap131.08B
Analysts84
Price Target164.66 (11.57%)
Short Float %1.65%
Short Ratio3.48
Dividend
Industry RankSector Rank
Dividend Yield 0.49%
Dividend Growth(5Y)0.22%
DP20.15%
Div Incr Years5
Div Non Decr Years5
Ex-Date11-04 2024-11-04 (0.175)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.05%
Min EPS beat(2)1.09%
Max EPS beat(2)13%
EPS beat(4)4
Avg EPS beat(4)5.69%
Min EPS beat(4)0.41%
Max EPS beat(4)13%
EPS beat(8)8
Avg EPS beat(8)5.7%
EPS beat(12)11
Avg EPS beat(12)7.77%
EPS beat(16)15
Avg EPS beat(16)10.27%
Revenue beat(2)1
Avg Revenue beat(2)11.35%
Min Revenue beat(2)-3.08%
Max Revenue beat(2)25.78%
Revenue beat(4)2
Avg Revenue beat(4)12.04%
Min Revenue beat(4)-3.93%
Max Revenue beat(4)29.4%
Revenue beat(8)5
Avg Revenue beat(8)24.62%
Revenue beat(12)7
Avg Revenue beat(12)19.92%
Revenue beat(16)11
Avg Revenue beat(16)60.9%
PT rev (1m)8.43%
PT rev (3m)16.99%
EPS NQ rev (1m)0.31%
EPS NQ rev (3m)-7.62%
EPS NY rev (1m)0.29%
EPS NY rev (3m)-3.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.27%
Valuation
Industry RankSector Rank
PE 33.24
Fwd PE 24.07
P/S 5.44
P/FCF 16.91
P/OCF 16.66
P/B 5.44
P/tB 8.02
EV/EBITDA N/A
EPS(TTM)4.44
EY3.01%
EPS(NY)6.13
Fwd EY4.16%
FCF(TTM)8.73
FCFY5.91%
OCF(TTM)8.86
OCFY6%
SpS27.14
BVpS27.11
TBVpS18.4
PEG (NY)0.83
PEG (5Y)3.12
Profitability
Industry RankSector Rank
ROA 0.83%
ROE 12.42%
ROCE 0.32%
ROIC 0.26%
ROICexc 0.28%
ROICexgc 0.35%
OM 4.08%
PM (TTM) 12.41%
GM 33.28%
FCFM 32.16%
ROA(3y)0.85%
ROA(5y)1.65%
ROE(3y)12.4%
ROE(5y)13.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-17.11%
ROICexcg growth 5Y9.7%
ROICexc growth 3Y-22.76%
ROICexc growth 5Y5.32%
OM growth 3Y-20.76%
OM growth 5Y4.13%
PM growth 3Y-17.4%
PM growth 5Y-10.34%
GM growth 3Y-19.32%
GM growth 5Y-11.66%
F-Score6
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF 6.42
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.49%
Interest Coverage 0.34
Cash Conversion N/A
Profit Quality 259.14%
Current Ratio 0.28
Quick Ratio 0.28
Altman-Z 0.21
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.87%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.93%
EPS 3Y24.32%
EPS 5Y10.67%
EPS Q2Q%56.82%
EPS Next Y40.03%
EPS Next 2Y33.91%
EPS Next 3Y30.02%
EPS Next 5Y23.48%
Revenue 1Y (TTM)78.71%
Revenue growth 3Y49.72%
Revenue growth 5Y42.06%
Sales Q2Q%36.28%
Revenue Next Year22.27%
Revenue Next 2Y30.7%
Revenue Next 3Y26.56%
Revenue Next 5YN/A
EBIT growth 1Y-58.37%
EBIT growth 3Y18.64%
EBIT growth 5Y47.93%
EBIT Next Year40.73%
EBIT Next 3Y30.07%
EBIT Next 5Y-5.11%
FCF growth 1Y193.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y195.38%
OCF growth 3YN/A
OCF growth 5YN/A